CellSource Co., Ltd. (JP:4880) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
CellSource Co., Ltd. will commence consolidated financial reporting starting from the fiscal year ending October 31, 2025, following the establishment of its subsidiary, Hybrid Medical Co., Ltd. The company has released its financial forecasts, projecting net sales of 4,501 million yen and a profit of 255 million yen for the upcoming fiscal year. These forecasts include the anticipated performance of Hybrid Medical.
For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue